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Modelling  of  gene  networks  is widely  used  in  systems  biology  to  study  the  functioning  of  complex
biological  systems.  Most  of  the existing  mathematical  modelling  techniques  are  useful  for analysis  of
well-studied  biological  processes,  for which  information  on  rates  of reactions  is available.  However,
complex  biological  processes  such  as  those  determining  the  phenotypic  traits  of  organisms  or  patho-
logical  disease  processes,  including  pathogen-host  interactions,  involve  complicated  cross-talk  between
interacting  networks.  Furthermore,  the intrinsic  details  of the  interactions  between  these  networks  are
often missing.  In  this  study,  we developed  an  approach,  which  we call  mosaic  network  modelling,  that
allows  the  combination  of independent  mathematical  models  of  gene  regulatory  networks  and,  thereby,
description  of  complex  biological  systems.  The  advantage  of this  approach  is  that  it  allows  us  to  generate
the integrated  model  despite  the fact that  information  on molecular  interactions  between  parts  of  the
model  (so-called  mosaic  fragments)  might  be  missing.  To  generate  a mosaic  mathematical  model,  we
used  control  theory  and  mathematical  models,  written  in  the  form  of  a system  of ordinary  differential
equations  (ODEs).  In  the  present  study,  we  investigated  the  efﬁciency  of  this  method  in modelling  the
dynamics  of more  than 10,000  simulated  mosaic  regulatory  networks  consisting  of two  pieces.  Analy-
sis  revealed  that this  approach  was highly  efﬁcient,  as the  mean  deviation  of  the  dynamics  of  mosaic
network  elements  from  the  behaviour  of the  initial  parts  of the model  was  less  than  10%.  It  turned  out
that  for  construction  of the control  functional,  data  on perturbation  of one  or two  vertices  of  the  mosaic
piece  are sufﬁcient.  Further,  we used  the  developed  method  to construct  a  mosaic  gene  regulatory  net-
work  including  hepatitis  C  virus  (HCV)  as  the  ﬁrst  piece  and  the  tumour  necrosis  factor  (TNF)-induced
apoptosis  and NF-B  induction  pathways  as  the  second  piece.  Thus,  the  mosaic  model  integrates  the
model  of  HCV  subgenomic  replicon  replication  with  the  model  of  TNF-induced  apoptosis  and  NF-B
induction.  Analysis  of  the  mosaic  model  revealed  that  the  regulation  of  TNF-induced  signaling  by  the
HCV network  is crucially  dependent  on  the RIP1,  TRADD,  TRAF2,  FADD,  IKK,  IB, c-FLIP,  and  BAR  genes.
Overall,  the  developed  mosaic  gene  network  modelling  approach  demonstrated  good  predictive  power
and allowed  the prediction  of new  regulatory  nodes  in  HCV  action  on  apoptosis  and  the  NF-B  pathway.
Those  theoretical  predictions  could  be a  basis  for  further  experimental  veriﬁcation.
©  2015  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license∗ Corresponding author at: The Federal Research Center Institute of Cytology
nd Genetics, The Siberian Branch of the Russian Academy of Sciences, Prospekt
avrentyeva 10, Novosibirsk 630090, Russia.
E-mail address: salix@bionet.nsc.ru (V.A. Ivanisenko).
ttp://dx.doi.org/10.1016/j.virusres.2015.10.004
168-1702/© 2015 The Authors. Published by Elsevier B.V. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Gene network modelling is a key approach in contempo-
rary biomedical research. There are a number of well-developed
methods for modelling the dynamics of gene network function
of well-studied biological processes on which comprehensive
information on relationships between all participants is avail-
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
72 O.V. Popik et al. / Virus Research 218 (2016) 71–78
F d circ
w ot-an
t
a
s
m
a
i
r
t
i
e
h
o
c
e
t
t
t
m
f
g
M
2
t
vig. 1. Schematic ﬁgure illustrating the networks of HCV replication (red arrows an
ays  of controlling of TNF- signalling pathways elements by viral proteins (orange d
he  reader is referred to the web  version of this article.)
ble. For example, models describing the dynamics of processes
uch as insulin-induced signaling (Yugi et al., 2014), cholesterol
etabolism (Mc  Auley et al., 2012), the circadian clock (Forger
nd Peskin, 2003), as well as models of the loss of acetylcholine
n Alzheimer’s disease (Ehrenstein et al., 2000), inﬂammation in
heumatoid arthritis (Baker et al., 2013), and inﬂuenza A virus infec-
ion (Fribourg et al., 2014), have been designed.
The most common methods of modelling gene network dynam-
cs are ﬂux models (Kauffman et al., 2003), kinetic models (Ishii
t al., 2007), and stochastic models (Voss et al., 2003). Each method
as its advantages and limitations. A problem common to all meth-
ds is determination of the parameters of the model (e.g. rate
onstants and initial concentrations). Usually the search for param-
ters is conducted by solving the inverse problem of the ﬁt between
he calculated and experimental kinetics, as well as by experimen-
al evaluation of parameters under conditions similar to those of
he modelled process.
There are a number of internet-accessible databases of mathe-
atical models describing the functioning of biological processes
or different organisms, including humans, animals, and microor-
anisms. In particular, the BioModels (Juty et al., 2015), CellML
odel (Lloyd et al., 2008), and The Cell Collective (Helikar et al.,
012) databases contain more than 600 mathematical models in
he form of ordinary differential equations (ODEs) collected from
arious publications. In addition, for each model, initial data andles) and TNF-signalling pathways (blue arrows and circles) with mapping possible
d-dash arrows). (For interpretation of the references to colour in this ﬁgure legend,
kinetic parameters are given. Mathematical models described in
these databases are designed to simulate the dynamics of highly
specialised, well-studied processes, for which experimental data
necessary to determine the parameters are available. At the same
time, it is known that most of phenotypic traits of organisms
are determined by a number of independent biological processes
(Gilman et al., 2011; Civelek and Lusis, 2014). The cross-talk
between such pathways is often very complicated and is realised
via the unknown additional pathways. In this study, we addressed
the problem of construction of integrated networks comprising dif-
ferent biological processes without obvious intersection by shared
genes. For gene networks that consist of a number of independent
gene networks and describe the interaction between biological pro-
cesses, we propose the term mosaic gene networks.
Mosaic gene network modelling can be accomplished by directly
integrating the models that describe the dynamics of individual so-
called “mosaic pieces.” The integration can be implemented in cases
where pieces are linked by common genes or there is an interaction
between pathways, which is known. Examples of such integration
of subnetworks are pathways from the KEGG database. An example
of a large pathway consisting of consequently connected individ-
ual metabolic pathways has been described (Kanehisa and Goto,
2000). In addition, there are cases of mosaic gene network mod-
elling using common elements and reconstruction of molecular
pathways via interaction between them. In particular, Peterson and
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iggs (2010) constructed a model that describes the interaction
etween the processes of calcium homeostasis and bone function.
nother example of model integration found in Walker et al. (2006)
escribes the effects of intercellular signaling through the epider-
al  growth factor receptor on cell proliferation.
A number of gene networks, however, cannot be constructed by
 simple association of mathematical models of individual path-
ays, because there are no data on intersection between the
omponents of these networks. However, there is much infor-
ation in the literature on an indirect evidence of interactions
etween components of gene networks that can be used for con-
truction and validation of mosaic gene regulatory networks. In
articular, there are databases containing experimental data on
hanges in the level of expression of the entire genome or indi-
idual genes in response to knockout or inhibition of a particular
ene or group of genes (Krupp et al., 2012; Leinonen et al., 2010).
his type of data could serve as a basis for analyzing the impact of
hanges in gene expression in one piece of the mosaic gene net-
ork on perturbation of gene expression in another piece, even
n the absence of detailed information on molecular interactions
etween the pieces.
In this study, we have proposed an approach to modelling of
osaic networks in which models of mosaic pieces are integrated.
his method has been found to be effective both in the analysis
f simulated genetic networks and in the integration of models of
ubgenomic HCV replicon replication and in the apoptosis induc-
ng pathway. Analysis of the mosaic gene network HCV/apoptosis
odel revealed good agreement with experimental data on gene
xpression changes of apoptosis genes in cells infected with HCV
Papic et al., 2012) and allowed prediction of target apoptosis genes
or HCV regulation. This approach to mosaic gene network mod-
lling can be used for the theoretical study of the mutual inﬂuence
f various biological processes and for the search for potential tar-
ets, ensuring effective management of one process by another.
. Materials and methods
.1. Description of the model integration method
To describe the dynamic of elements of the full mosaic gene
etwork, we used the control functional. The aim was to build a
unctional that describes a process of control of one gene subnet-
ork by another based on analysis of the perturbation elements
f the ﬁrst network and the response to this perturbation of the
econd network.
We  describe an algorithm as an example of the integration
f two models of biological processes involving N and M ele-
ents. The set of variables of the ﬁrst model is denoted as Y (t) =
1 (t) , Y2 (t) , ..., YN (t), and the variables of the second model have
een denoted as U (t) = U1 (t) , U2 (t) , ..., UM (t), where Yi (t) and
j (t) are the concentrations of elements i and j at time t.The ﬁrst
odel, which describes the biological process that controls the sec-
nd process, is given as a system of differential equations in the
orm
dYi (t)
dt
Pi (Y1, Y2, ..., YN) − Di (Y1, Y2, ..., YN) , i = 0, 1, ., N (1)
here Pi = a term of the equations describing the production of Yi,
nd Di = a term of the equations describing the degradation ofYi.
We deﬁne the second model as a system of differential equations
n the form
dUj (t)
dt
= Fj (U1, U2, ..., UM) , j = 0, 1, ., M.  (2)rch 218 (2016) 71–78 73
The integrated model can be described by the system of equa-
tions{
dYi (t)
dt
= Pi (Y1, Y2, ..., YN) − Di (Y1, Y2, ..., YN)
}
(3)
{
dUj (t)
dt
= Fj (U1, U2, ..., UM) +  (K1, K2, ..., KN, Y1, Y2, ..., YN)
}
(4)
where  (K1, K2, . . .,  KN, Y1, Y2, . . .,  YN) =
∑
j=1,..,NKj × Yj is the
control functional.
2.2. Estimation of the parameters of the control functional
The search for parameters is based on the analysis of experimen-
tal data on the perturbation of the elements of the ﬁrst model and
the response of the second model to this perturbation of elements.
As perturbation, we considered element production suppression,
which for example may  result from the inhibition of gene expres-
sion. If experimental data on the inhibition of R elements of the ﬁrst
system are given, the response of the second system is presented
in the form of a set of measured concentrations of its elements{
UˆJ (t)
}L
, (j  = 0, 1, ., L). UˆJ (t) can be presented in form of continu-
ous function, or as set of concentrations values at some time points
or even just by steady state value.
To ﬁnd the parameters, we solved the problem of minimizing the
difference between element dynamics calculated by the model and
obtained in the experiment study. The value of objective function
is the sum of differences for each case of inhibition and responses
and can be presented in the form
S =
∑R
P
(
1
L
∑L
j
j), (5)
where j = the square root of the mean square deviation of the
dynamics element of the second model from the experimental
dynamics. j is calculated using the formula
j =
√
1
T
∑T
=1
(
UˆJ () − U˜J ()
UˆJ () + U˜J ()
)2
(6)
where T = the number of experimental points of the dynamics
UˆJ , U˜J () = U˜J(t)t= , value of calculated by the model dynamic
of expression level of gene j at time point . Value of deviation
between experimental and model values UˆJ () − U˜J () at each
experimental time point  is normalized by dividing on sum UˆJ () +
U˜J () and then we  calculate root mean square between experimen-
tal and model data.
To simulate the effect of inhibition of elements of the ﬁrst sys-
tem, we deﬁne the parameter p, which characterises the degree
of reduction of element Yp production. Thus, the system of Eqs. (3),
(4) for each inhibition case (p = 0, 1, ..., R) is written in the form{
dYp (t)
dt
= p × Pp (Y1, Y2, ..., YN) − Dp (Y1, Y2, ..., YN)
}
(7)
{
dYi (t)
dt
= Pi (Y1, Y2, ..., YN) − Di (Y1, Y2, ..., YN) , i /= p
}
(8)
{
dU˜J (t)
dt
= Fj
(
U˜1, U˜2, ..., U˜M
)
+  (K1, K2, ..., KN, Y1, Y2, ..., YN ) , j  = 0, 1, ., M
}
(9)The search for functional coefﬁcients was  performed using a
genetic algorithm (Bäck, 1996) that minimises S from Eq. (5).
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.3. Generation of simulated mosaic gene regulatory networks
To construct mosaic regulatory gene networks, we  used the
NDSystem (Demenkov et al., 2012; Ivanisenko et al., 2015), con-
aining information on the interactions between genes, proteins,
etabolites, microRNA, and other elements. Information on molec-
lar and genetic interactions in the ANDSystem was obtained by
utomatic analysis of texts of scientiﬁc publications and extracted
rom a variety of factual databases. To generate the initial gene
etwork, a pair of proteins linked by a linear pathway result-
ng in a chain 7–15 proteins long were randomly selected from
NDSystem. As the interactions between the proteins in the chain,
e considered connections of all types in the ANDSystem. This
et of randomly selected linear chains also provides the basis for
onstruction of the initial network. To complete the network, all
lements satisfying the requirement that each of them is linked
o at least two vertices of the base chain were extracted from the
NDSystem.
The reconstructed network is a structural basis for the further
onstruction of regulatory networks. The regulatory network is cre-
ted by the random distribution of the directions of regulation along
he edges of the structural template. The regulatory initial full net-
ork was modiﬁed into the mosaic network, that consists of two
ieces and interactions that connect those pieces in the full network
re excluded by following algorithm. We  formed a set of vertices
or the ﬁrst and second pieces of the network: (i) from the set of
ll linear chains of nodes in the initial network with length of at
east seven elements, we randomly chose one. The basis for the
rst subnetwork consists of three primary vertices of the selected
hain, whereas the basis for the second subnetwork consists of the
ast three vertices of the selected chain. (ii) To simulate the lack of
nformation on the links between the two pieces of the mosaic net-
ork, we excluded other nodes from the chain. (iii) In order to grow
ubnetworks for each piece from the linear chain with condition
hat subnetworks do not overlap and do not directly interact with
ach other, we extended basis of each subnetwork by adding ran-
omly selected nodes from original network nodes that had at least
wo interactions with the basic chain of the corresponding mosaic
iece. At the same time, we required that one vertex could be added
nly to the one piece. Any interactions between two pieces were
xcluded to simulate the lack of information on the links between
iological processes, which underlies the initial network.
Each vertex of the network is represented by a gene. For the
riginal gene network, we set all the parameters of the reactions
ates and the initial conditions. On the basis of these data, we  wrote
 mathematical model of the initial network in the form of an ODE
ystem. We  obtained the model for the mosaic network from the
nitial gene network using the approach described under Descrip-
ion of the Model Integration Method.
.4. Modelling of simulated gene regulatory networks
To simulate the gene regulatory networks, in the Eqs. (1)–(2)
nd (3)–(4), describing the dynamics of the initial gene networks,
e set the right sides of the equations as
i (Y1, Y2, . . .,  YN) =
1 +
∑
k∈Ui˛i,kY
hi,k (t)
1 +
∑
k∈Diıi,kY
i,k (t)
, (10)
i (Y1, Y2, . . .,  YN) = −ˇiYi (t) (11)
1 +∑k∈Ui˛i,kUhi,k (t)
j (U1, U2, . . .,  UM) = 1 +
∑
k∈Dii,kU
i,k (t)
− ˇiUi (t) (12)
here Ui = a set of elements positively regulating the activity of
lement i synthesis, Di = a set of elements negatively regulatingrch 218 (2016) 71–78
the activity of element i synthesis, ˛i,k and ıi,k = regulation con-
stants, hi,k and i,k = the parameters of nonlinearity, and ˇi = the
degradation rate constant. The above form of the equations is often
used in the simulation of regulatory gene networks (Demidenko
et al., 2004). To simulate inhibition of the element Yp, we  mul-
tiply right term of the equation (10) on inhibition parameterp,
Pp (Y1, Y2, . . .,  YN) = p
1+
∑
k ∈  Ui
˛i,kY
hi,k (t)
1+
∑
k ∈  Di
ıi,kY
i,k (t)
.
In the simulation, parameters were set randomly in the ranges
0 < p < 1, 0 < ˛i,k < 2, 0 < ıi,k < 2, 0 < ˇi < 2, hi,k and i,k ∈{
0, 1, 2
}
. The initial data were set to 1 for all elements.
2.5. Mosaic model of subgenomic HCV replicon replication and
apoptosis
For construction of the mosaic gene network of HCV replica-
tion and TNF-induced apoptosis and NF-B regulation, the model of
subgenomic HCV replicon replication (Binder et al., 2013) and the
model of TNF signaling pathways (Schliemann et al., 2011) were
taken. Binder et al. described subgenomic HCV replicon replication
in a hepatoma cell line. The model is deﬁned by a system of 11
ODEs and describes the dynamics of viral RNA and viral proteins in
cell culture after transfection. Schliemann et al. developed a model
for the study of TNF-R1 signaling, the TNF-induced NF-B pathway,
and the caspase activation pathway. The model topology included
the formation of complex I leading to the induction of NF-B and of
complex II leading to the induction of apoptosis. The model is rep-
resented by an ODE system consisting of 47 equations involving 47
variables.
To simulate the mosaic network, we developed an integrated
model using the Eqs. (3)–(4).{
dYi (t)
dt
= Pi (Y1, Y2, ..., YN) − Di (Y1, Y2, ..., YN) , i = 0, 1, ., M
}
(13)
{
dU˜J (t)
dt
= Fj
(
U˜1, U˜2, ..., U˜M
)
+  (K1, K2, ..., KN, Y1, Y2, ..., YN ) , j = 0, 1, ., M
}
(14)
Expressions for Pi, Di, and Fj were set according to the equa-
tions of the Binder et al. and Schliemann et al. models, using the
same parameters as in the original models. The integrated system
includes 58 equations and 58 variables (Supplementary Table S1,
S2). In the model, the direction of the regulation is from HCV pro-
teins to the set of nodes from TNF signaling pathway (Fig. 1). As
target nodes, which should be under the control of HCV proteins,
we selected all proteins from the model of Schliemann et al. that
according to the literature data might have the strongest effect on
the signaling outcome (Supplementary Table S1). The total number
of such nodes was 18. To investigate the best targets of HCV action,
we considered the case of all 18 vertices, as well as cases of differ-
ent combinations of controlled nodes. Consequently, the number
of parameters in the control functional  (K1, K2, . . .,  KN, Y) varied
from 3 to 18.
To ﬁnd the parameters, we used data from the work Papic et al.
(2012), who  performed a transcriptome analysis of genes in the
hepatoma cell line Huh7 infected with HCV. Papic et al. showed dif-
ferential expression of more than 1,800 human genes in the infected
cells. To determine the parameters of the mosaic network model,
it is necessary to have data describing perturbation in one piece of
the mosaic network and the response to this perturbation in the
other piece. In this case, the disturbance is activation of the viral
polyprotein production and, as a result, a presence of viral proteins
 Research 218 (2016) 71–78 75
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n individual infected cells, whereas in the uninfected cells, these
roteins are absent. Viral proteins might modulate participants of
he TNF signaling pathway, leading to changes in their dynamics.
s a response of the second pieces of the mosaic gene network, we
onsidered the changes in the levels of expression of genes that are
resented in the model of Schliemann et al. (2011). For a number of
enes from that model (TNFR, RIP1, TRADD, TRAF2, FADD, IKK, IB,
nd Casp8), there were experimental data on expression changes
n cells infected with HCV. According to the experiment, 6, 48, and
2 h after infection with HCV, the culture contained 40%, 80%, and
5% infected cells, respectively (Papic et al., 2012). We  assumed that
he time interval for cell infection obeys an exponential distribu-
ion. Factor  characterises an average number of infected cells per
ime unit and was estimated from the dynamics of the percentages
f infected cells at different intervals. Then, the average expression
f gene j in the cell culture can be expressed through the expres-
ion of this gene in a single cell, taking into account the time of cell
nfection with HCV, with the formula
¯ J (T) = ˛
∫ T
0
e−˛tEj (T − t)dt (15)
here E¯J (T) = experimentally measured (averaged over the cell
ulture) expression of gene j at time T, and Ej (T − t) = estimated
xpression of gene j at time T in the single cell that has been infected
t time t. To evaluate the expression of gene j in the mosaic network
odel, Ej (T − t) is replaced by U˜J (T − t):
 = Nj E¯J (T) − ˛
∫ T
0
e−˛tU˜J (T − t)dt (16)
hus, the evaluation of the parameters K1, K2, . . .,  KN of the control
unctional was  performed by minimizing the difference S. Mini-
ization was performed using a genetic algorithm (Bäck, 1996).
The model was validated by dividing the experimental data into
wo parts: training (70%) and control (30%) samples. The parame-
ers of the integration functional were deﬁned using the training
ample; the control sample was used to assess the accuracy of the
odel. For validation, we also used different combinations of ver-
ices, which are controlled by the functional. As a result, it was
onﬁrmed that RIP1, TRADD, TRAF2, FADD, IKK, IB, c-FLIP, and
AR are the best target genes for control of the TNF-induced apo-
tosis and NF-B induction pathways by HCV. For this case, the
ntegrated model allowed us to describe the experimental data in
he control sample with the smallest error, which was less than
0%.
. Results and discussion
.1. Analysis of simulated mosaic gene regulatory networks
The function of biological processes depends on production
f gene products, and genes expression is determined by genetic
egulations. In this respect, the regulatory gene networks are an
mportant focus of research in systems biology. To simulate such
etworks, well-developed approaches based on different math-
matical methods are used. Such methods allow users to easily
onvert the graph of the gene network into a system of ordinary dif-
erential equations. In turn, we used that feature of regulatory gene
etworks for mass analysis of gene regulatory networks and, there-
ore, explored the applicability of our approach to the modelling of
osaic gene networks. We  reconstructed more than 10,000 sim-
lated gene regulatory networks. On the basis of these networks,
osaic gene networks were generated (see Section 2.3). The dis-
ribution of the number of vertices in initial networks is illustrated
n Fig. 2. More than a quarter of the networks had more than 17
ertices, median number of edges is 49 and the average numberFig. 2. Distribution of the number of initial gene regulatory networks by number of
vertices.
of edges outgoing from single vertex is three. Further, the initial
networks were divided into subnetworks (pieces of the mosaic net-
works). It turned out that the average number of vertices calculated
for the pieces was 5, and the average number of connections was
8.
Mathematical models describing the functioning of networks in
terms of ODEs were constructed for each initial network, as well as
for their mosaic pieces. In our approach, we obtained the mosaic
network models by integrating the pieces using the control func-
tional (see Section 2.1). We  considered mosaic networks consisting
only of two  pieces, where one piece controls the dynamics of the
other.
We compared the results of simulations of the initial genetic reg-
ulatory networks with the results of the mosaic genetic regulatory
networks constructed from them. To achieve the best construc-
tion of a mosaic model, we had to answer the following questions:
How does the error of the mosaic model depend on the number
of vertices subjected to perturbation from one piece of the mosaic
network, on the one hand, and the number of vertices of the sec-
ond piece, for which data on the response to these disturbances are
necessary, on the other hand? What number of vertices should be
considered in the control functional, integrating the two pieces of
the mosaic network?
We analyzed different variants of vertices to perturb and ver-
tices subjected to control on a set of simulated gene regulatory
networks. For each simulated gene regulatory network, we con-
sidered all possible combinations of inhibition of elements in the
ﬁrst subnetwork in combination with different vertices from the
second subnetwork, which are controlled by the functional. From
all the combinations, we  chose the best set, in which the deviation
between the mosaic and the initial network model behaviours is
minimal. According to our estimates, in 25% of the cases, inhibi-
tion of one vertex of the control piece of the mosaic is sufﬁcient.
Surprisingly for us, in 73% cases, inhibition of only two vertices
was enough for good agreement between the mosaic and the initial
network (difference is not more than 10%). Inhibition of the third
vertex of the control piece of the mosaic network did not reduce
the magnitude of the difference. The distribution of the minimum
values of deviations between the mosaic and the initial networks
is illustrated in Fig. 3.
3.2. Mosaic gene network describing HCV-host interaction
It is well known that HCV controls the process of apoptosis
in cells. In addition, there are many well-developed models that
describe how the infection occurs at the intracellular level (for
cells replicating a subgenomic HCV replicon) (Binder et al., 2013;
Ivanisenko et al., 2014) and at the organism level (Guedj et al.,
2013; Nakabayashi, 2012). There are also models that describe the
molecular mechanisms underlying the apoptosis-inducing path-
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ay (Neumann et al., 2010; Legewie et al., 2006; Kallenberger et al.,
014). However, a model that describes the inﬂuence of HCV on
poptosis has not yet been developed. To solve this problem, we
sed the approach described above to model the mosaic gene net-
ork. The mosaic gene network has been presented in the form
f subnetworks of subgenomic HCV replicon replication and apo-
tosis processes. As a model for the replication of the subgenomic
CV replicon, we used the model of Binder et al. (2013), as it is
epresented in the form of an ODE system suitable for use in this
ntegration approach. Also, the model provides a good prediction
f the dynamics of viral RNA in the ﬁrst 3 days after transfection by
iral RNA, which is quite suitable, as the experimental data we  use
n our approach show changes in the dynamics of gene expression
n cells infected with HCV for 1–3 days after infection (Papic et al.,
012). As a model describing the process of apoptosis, we  chose the
odel generated by Schliemann et al. (2011), which describes TNF
ignaling and comprises apoptotic signaling induced through com-
lex II and NF-B signaling induced through complex I. This model
ombines the pro-apoptotic signaling induced by formation of the
omplex II leading to caspase-8 activation and the anti-apoptotic
ignaling induced by formation of complex I resulting in activation
f the transcription factor NF-B (Mischeu and Tschopp, 2003). By
electing this model for our analysis, we could combine both the
ro-apoptotic and anti-apoptotic actions of HCV infection on the
NF signaling pathway. The model contained eight variables refer-
ing to genes whose expression was changed in cells upon infection
ith HCV in the experiments of Papic et al. (2012).
To calculate the dynamics of gene expression averaged over the
ell culture, we used Eq. (16), which revealed that the dynamics of
ene expression predicted by the model are in good agreement with
he experimental data. Fig. 3 illustrates the calculated and experi-
ental kinetics of ﬁve of eight genes for which experimental data
or expression were available (Papic et al., 2012). In addition, the
redicted dynamics of expression of the c-FLIP gene during infec-
ion are illustrated. The ﬁve genes are the genes from the model for
hich expression markedly increased 72 h after initial infection of
he cells. These genes include FADD, RIP1, and TRADD. There was no
lear increase in the expression of IB and BAR, which are included
nly to illustrate the ﬁt between experimental data and model pre-
ictions. Predicted dynamics of c-FLIP indicate an increase, though
o experimental data were available for this gene.
Analysis of the integrated model revealed that the most effec-
ive target genes for control from the HCV side were RIP1, TRADD,
RAF2, FADD, IKK, IB, c-FLIP, and BAR. According to experimen-the integrated mosaic model and the initial network model.
tal data (Papic et al., 2012), the expression of six genes (RIP1,
TRADD, TRAF2, FADD, IKK, IB) changed in HCV-infected cells.
It is well known that stimulation of TNF-R (tumor necrosis factor
receptor 1) results in the formation of two signaling complexes:
complex I and complex II (Micheau and Tschopp, 2003). Com-
plex I comprises the adaptor molecule TRADD (TNF-R-associated
death domain protein), RIP1, TRAF-1/2, cIAP-1/2 (cellular inhibitor
of apoptosis), and LUBAC (linear ubiquitin chain assembly complex)
containing HOIL (heme-oxidised IRP2 ligase), HOIP, and Sharpin
forming TNF-R1 complex (Haas et al., 2009). Complex I promotes
NF-B activation via attachment of polyubiquitin chains to RIP1
and recruitment of NEMO (Haas et al., 2009). Complex II comprises
FADD, caspase-8, and c-FLIP, but lacks a receptor (Micheau 2003).
Complex II serves as a platform for the activation of caspase-8 and
apoptosis induction. The activation of caspase-8 in complex II, and
therefore apoptosis induction, is counteracted by the c-FLIP pro-
tein, which plays a central inhibitory role in TNF-induced apoptosis
(Öztürk et al., 2012). It has been found experimentally that the HCV
nonstructural protein NS5A inhibits TNF--induced apoptosis in
cells (Ghosh et al., 2000) and is associated in vitro with TRADD.
These results suggest that NS5A perturbs the function of TRADD for
the recruitment of TRAF2/RIP probably by interacting with TRADD
(Majumder et al., 2002).
Importantly, the modelling demonstrated the concomitant
increase in the expression of anti-apoptotic genes after infection.
It has been reported before that HCV infection leads to the inhibi-
tion of apoptosis (Kountouras et al., 2003; Chou et al., 2005); the
increase in c-FLIP expression might account for this effect, as sub-
tle changes in c-FLIP expression have been found to have a major
impact on the onset of apoptosis (Fig. 4). In addition, we  observed an
increase in the genes from the TNF-induced NF-B pathways (RIP1,
TRADD, TRAF2, FADD, IKK, and IB). Activation of the transcription
factor NF-B has been found to have a strong anti-apoptotic effect in
a number of tissues by leading to the upregulation of anti-apoptotic
proteins such as Bcl-2 and c-FLIP (Lavrik, 2012).
In conclusion, we proposed an approach to the integration of
models of mosaic pieces using the “control functional.” The control
functional is an extra term that depends on the concentrations of
the elements of a model for one mosaic piece and is added to a
model of the second piece. Thus, it represents the effect that the
ﬁrst piece has on the second piece. The control functional is con-
structed on the basis of experimental data on the perturbation of
elements in the ﬁrst mosaic subnetwork and the response of the
dynamics of gene expression in the second subnetwork. Properties
O.V. Popik et al. / Virus Resea
Fig. 4. Calculated and experimental dynamics of gene expression during infection
of  human cells by HCV. Magenta lines represent genes whose expression levels sig-
niﬁcantly changed: RIP1, TRADD, FADD, IBa, and BAR. The scale for concentration
varies from 0 to 0.4 M.  On the right side of the ﬁgure, the scale in red is for the
expression level of c-FLIP; it varies from 8.5 × 1−3 to 9.2 × 10−3 M. (For interpre-
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f models obtained using the suggested approach were studied in a
arge number of generated mosaic gene regulatory networks with
ifferent structures. Such mosaic gene regulatory networks were
esigned on the basis of generated gene regulatory networks by
eduction of interactions between subnetworks. We  analyzed the
redictive power of mosaic network models, as well as the sets of
enes and changes in their expression levels that are necessary for
onstructing models with suitable predictive power. To estimate
redictive power, we compared the behaviour of a mosaic net-
ork model with the behaviour of an initial gene network. Analysis
evealed the high efﬁciency of the developed method; for example,
he average deviation between mosaic and initial networks was less
han 10%. Moreover, we showed that data on the perturbation of
ne or two vertices of the pieces was sufﬁcient to build a control
unctional.
The developed approach was applied to the model of the mosaic
etwork describing interaction between processes of replication
f the hepatitis C virus (HCV) subgenomic replicon and tumor
ecrosis factor (TNF)-induced apoptosis and NF-B activation. It
s well known that HCV strictly controls the process of apoptosis in
nfected cells, leading to the inhibition of this type of programmed
ell death (Kountouras et al., 2003; Chou et al., 2005). For construc-
ion of the mosaic gene network, we used the deterministic model
f subgenomic HCV replication from Binder et al. (2013) and the
odel of the TNF-induced apoptotic and NF-B signaling pathways
rom the work of Schliemann et al. (2011). The parameters of the
ontrol functional were determined using experimental data on
he effect of HCV infection in the Huh7 hepatoma cell line (Papic
t al., 2012). It was found that HCV infection modulates TNF sig-
aling through the RIP1, TRADD, TRAF2, FADD, IKK, IB, c-FLIP,
nd BAR genes. This provides a new systematic view of the gene
etwork regulating a response to HCV infection and paves the way
o development of target approaches against HCV infection.
The suggested method was applied for cases of mosaic network
onsisting of two pieces and one piece controls other. Further, we
re planning to extend method on case of mosaic network of three
nd more pieces inﬂuencing each other. On ﬁrst step, we are going
o solve the task of mutual inﬂuence of two mosaic pieces by using
wo control functionals. Other direction of study is to investigate
tructural properties of the control functional, of the networks and
o ﬁnd out best combinations of inhibited and target elements in
rder to clarify what kind of experimental data is necessary to con-rch 218 (2016) 71–78 77
struct good model and evaluate how the control functional could
help to recover real interactions between processes.
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